(84) |
Designated Contracting States: |
|
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO
SE SI SK TR |
(30) |
Priority: |
19.05.2006 US 801400 P
|
(43) |
Date of publication of application: |
|
18.02.2009 Bulletin 2009/08 |
(73) |
Proprietor: Viroblock SA |
|
1228 Plan-les-Ouates (CH) |
|
(72) |
Inventors: |
|
- PELET, Thierry
1219 Le Lignon (CH)
- WALLACH, Donald, F., H.
1208 Geneva (CH)
|
(74) |
Representative: KATZAROV S.A. |
|
European Patent Attorneys
19, rue des Epinettes 1227 Genève 1227 Genève (CH) |
(56) |
References cited: :
WO-A1-02/43742 US-A- 5 561 062
|
US-A- 4 911 928 US-A1- 2005 015 847
|
|
|
|
|
- K.V. KHANNA ET AL: "Vaginal transmission of cell-associated HIV-1 in the mouse is
blocked by a topical, membrane-modifying agent" JOURNAL OF CLINICAL INVESTIGATION,
vol. 109, no. 2, 2002, pages 205-211, XP002412282
- P. DANTHI AND M. CHOW: "Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus
entry" JOURNAL OF VIROLOGY, vol. 78, no. 1, 2004, pages 33-41, XP002412283
- Z. LIAO ET AL.: "Lipid rafts and HIV pathogenesis: host membrane cholesterol is required
for infection by HIV Type 1" AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 17, no. 11,
2001, pages 1009-1019, XP002412400
- R.C.TUCKEY ET AL.: "Transfer of cholesterol between phospholipid vesicles mediated
by the steroidogenic acute regulatory protein (StAR)" JOURNAL OF BIOLOGICAL CHEMISTRY,
vol. 277, no. 49, 2002, pages 47123-47128, XP002412401
|
|